ビジネス · 2002/10/231 分で読めます
Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Adverse Drug Experience Reporting
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Postmarketing Adverse Drug Experience Reporting" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA).